These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24499090)

  • 1. Proteomic analysis of proteins eliminated by low-density lipoprotein apheresis.
    Yuasa Y; Osaki T; Makino H; Iwamoto N; Kishimoto I; Usami M; Minamino N; Harada-Shiba M
    Ther Apher Dial; 2014 Feb; 18(1):93-102. PubMed ID: 24499090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
    Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics Approach Identifies Factors Associated With the Response to Low-Density Lipoprotein Apheresis Therapy in Patients With Steroid-Resistant Nephrotic Syndrome.
    Kuribayashi-Okuma E; Shibata S; Arai S; Ota T; Watanabe S; Hisaki H; Okazaki T; Toda T; Uchida S
    Ther Apher Dial; 2016 Apr; 20(2):174-82. PubMed ID: 26771065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein adsorption during LDL-apheresis: proteomic analysis.
    Dihazi H; Koziolek MJ; Söllner T; Kahler E; Klingel R; Neuhoff R; Strutz F; Mueller GA
    Nephrol Dial Transplant; 2008 Sep; 23(9):2925-35. PubMed ID: 18398017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
    Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
    Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is lipoprotein (a)-apheresis useful?
    Bambauer R
    Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of LDL-apheresis--more than reduction of cholesterol?].
    Schettler V; Wieland E
    Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL apheresis and inflammation--implications for atherosclerosis.
    Hovland A; Lappegård KT; Mollnes TE
    Scand J Immunol; 2012 Sep; 76(3):229-36. PubMed ID: 22670805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
    McGowan MP
    J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different inflammatory responses induced by three LDL-lowering apheresis columns.
    Hovland A; Hardersen R; Sexton J; Mollnes TE; Lappegård KT
    J Clin Apher; 2009; 24(6):247-53. PubMed ID: 19927364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different LDL apheresis methods.
    Julius U; Frind A; Tselmin S; Kopprasch S; Poberschin I; Siegert G
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):629-39. PubMed ID: 18510481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
    Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
    Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles.
    Hovland A; Marcovina S; Hardersen R; Enebakk T; Mollnes TE; Lappegård KT
    Transfus Apher Sci; 2012 Feb; 46(1):73-6. PubMed ID: 22206792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
    Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
    Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
    Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
    Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.